DOI QR코드

DOI QR Code

Mortality Characteristics and Prediction of Female Breast Cancer in China from 1991 to 2011

  • Shi, Xiao-Jun (Department of Preventive Medicine, Shantou University Medical College) ;
  • Au, William W. (Department of Preventive Medicine, Shantou University Medical College) ;
  • Wu, Ku-Sheng (Department of Preventive Medicine, Shantou University Medical College) ;
  • Chen, Lin-Xiang (Department of Preventive Medicine, Shantou University Medical College) ;
  • Lin, Kun (Department of Preventive Medicine, Shantou University Medical College)
  • Published : 2014.03.30

Abstract

Aims: To analyze time-dependent changes in female breast cancer (BC) mortality in China, forecast the trend in the ensuing 5 years, and provide recommendations for prevention and management. Materials and Methods: Mortality data of breast cancer in China from 1991 to 2011 was used to describe characteristics and distribution, such as the changes of the standardized mortality rate, urban-rural differences and age differences. Trend-surface analysis was used to study the geographical distribution of mortality. In addition, curve estimation, time series modeling, Gray modeling (GM) and joinpoint regression were performed to estimate and predict future trends. Results: In China, the mortality rate of breast cancer has increased yearly since 1991. In addition, our data predicted that the trend will continue to increase in the ensuing 5 years. Rates in urban areas are higher than those in rural areas. Over the past decade, all peak ages for death by breast cancer have been delayed, with the first death peak occurring at 55 to 65 years of age in urban and rural areas. Geographical analysis indicated that mortality rates increased from Southwest to Northeast and from West to East. Conclusions: The standardized mortality rate of breast cancer in China is rising and the upward trend is predicted to continue for the next 5 years. Since this can cause an enormous health impact in China, much better prevention and management of breast cancer is needed. Consequently, disease control centers in China should place more focus on the northeastern, eastern and southeastern parts of China for breast cancer prevention and management, and the key population should be among women between ages 55 to 65, especially those in urban communities.

Keywords

References

  1. Anderson WF, Chu KC, Chang S (2003). Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities. J Clin Oncol, 21, 2254-59. https://doi.org/10.1200/JCO.2003.07.082
  2. Bambhroliya AB, Burau KD, Sexton K (2012). Spatial analysis of county-level breast cancer mortality in Texas. J Environ Public Health, 959343.
  3. Cancer incidence in five continents. Volume IX (2008). IARC Sci Publ, 1-837.
  4. Chen JG, Zhu J, Parkin DM, et al (2006). Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer, 119, 1447-54. https://doi.org/10.1002/ijc.21952
  5. China health statistics yearbook (2007). Beijing: Peking Union Medical College Publication House.
  6. China health statistics yearbook (2009). Beijing: Peking Union Medical College Publication House.
  7. China health statistics yearbook (2010). Beijng: Peking Union Medical College Publication House.
  8. China health statistics yearbook (2011). Beijing: Peking Union Medical College Publication House.
  9. Cox B (2008). The effect of service screening on breast cancer mortality rates. Eur J Cancer Prev, 17, 306-11.
  10. Curado MP. (2011). Breast cancer in the world: incidence and mortality. Salud Publica Mex, 53, 372-84.
  11. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  12. Franco-Marina F, Lazcano-Ponce E, Lopez-Carrillo L (2009). Breast cancer mortality in Mexico: an age-period-cohort analysis. Salud Publica Mex, 51, 157-64. https://doi.org/10.1590/S0036-36342009000800005
  13. Gao YT, Shu XO, Dai Q, et al (2000). Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer, 87, 295-300. https://doi.org/10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7
  14. Lee CH. (2002). Screening mammography: proven benefit, continued controversy. Radiol Clin North Am, 40, 395-407. https://doi.org/10.1016/S0033-8389(01)00015-X
  15. Li CI, Malone KE, Daling JR (2003). Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med, 163, 49-56. v https://doi.org/10.1001/archinte.163.1.49
  16. Li CI, Malone KE, Daling JR, et al (2008). Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol, 167, 230-9.
  17. Kun Lin, Wenying Shen, Zhongying Shen. (2002). Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China. Int J Cancer, 102, 207-11. https://doi.org/10.1002/ijc.10698
  18. Kun Lin, Yongning Wu, Wenying Shen. (2009). Interaction of total N-nitroso compounds in environment and in vivo on risk of esophageal cancer in the coastal area, China. Environ Int, 35, 376-81. https://doi.org/10.1016/j.envint.2008.09.005
  19. Robles S C, Galanis E. (2002). Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica, 11, 178-85.
  20. Roy R, Chun J, Powell SN (2012). BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer, 12, 68-78.
  21. Shapiro S, Coleman EA, Broeders M, et al (1998). Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. international breast cancer screening network (IBSN) and the european network of pilot projects for breast cancer screening. Int J Epidemiol, 27, 735-42. https://doi.org/10.1093/ije/27.5.735
  22. Smigal C, Jemal A, Ward E, et al (2006). Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, 56, 168-83. https://doi.org/10.3322/canjclin.56.3.168
  23. Vervoort MM, Draisma G, Fracheboud J, et al (2004). Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer, 91, 242-7.
  24. Huanxin W, Nan H (1991). Trend-surface analysis was applied to the study of the geographic distribution for LBWI in China. Chinese J Hlth Stat, 8, 12.
  25. Whelan SL, Ferlay J (1992). Cancer incidence in five continents. Age-specific and standardized incidence rates. IARC Sci Publ, 178-861.
  26. Yang L, Li L, Yude C (2005). Cancer incidence and mortality estimates and prediction for year 2000 and 2005 in China. Chinese J Hlth Stat, 22, 218-31.
  27. Zhao P, Chen WC (2008). Chinese Cancer Registry Annual Report, 2004. Beijing: Peking Union Medical College Publication House.
  28. Zhao P, Chen Wc (2009). Chinese Cancer Registry Annual Report, 2008-Cancer Incidence And Mortality In Chinese Cancer Registration Areas In 2005. Beijing: Military Medical Science Press.
  29. Zhao P, Chen Wc (2010). Chinese Cancer Registry Annual Report 2009-Cancer Incidence And Mortality In Chinese Cancer Registration Areas In 2006. Beijing: Military Medical Science Press.
  30. Zhao P, Chen Wc (2011). Chinese Cancer Registry Annual Report 2010-Cancer Incidence And Mortality In Chinese Cancer Registration Areas In 2007. China,Beijing: Military Medical Science Press.
  31. Zhao P, Chen Wc (2012). Chinese Cancer Registry Annual Report,2011. Beijing, China: Military Medical Science Press.
  32. Zhu Chen,(2008). The Third National Mortality Retrospective Sampling Survey Report. Beijing: Peking Union Medical College Publication House.

Cited by

  1. Awareness of Risk Factors for Cancer among Omani adults- A Community Based Study vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5401
  2. Emodin Inhibits Breast Cancer Cell Proliferation through the ERα-MAPK/Akt-Cyclin D1/Bcl-2 Signaling Pathway vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6247
  3. Epidemiological Characteristics and Prediction of Esophageal Cancer Mortality in China from 1991 to 2012 vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6929
  4. Breast Cancer Diagnosis by Mammography in Kazakhstan - Staging Results of Breast Cancer with Double Reading vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.31
  5. Characteristics and Prediction of Lung Cancer Mortality in China from 1991 to 2013 vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5829
  6. Cervical Cancer Mortality Trends in China, 1991-2013, and Predictions for the Future vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6391
  7. Mortality Characteristic and Prediction of Nasopharyngeal Carcinoma in China from 1991 to 2013 vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6729
  8. Spatial and Temporal Epidemiological Assessment of Breast Cancer Incidence and Mortality in Kazakhstan, 1999-2013 vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6795
  9. Liver Cancer Mortality Characteristics and Trends in China from 1991 to 2012 vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1959
  10. Innovation Status of Gene Therapy for Breast Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.4133
  11. FYN promotes breast cancer progression through epithelial-mesenchymal transition vol.36, pp.2, 2016, https://doi.org/10.3892/or.2016.4894
  12. Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase vol.16, pp.1, 2017, https://doi.org/10.3892/mmr.2017.6638
  13. Circular RNA hsa_circ_0001982 Promotes Breast Cancer Cell Carcinogenesis Through Decreasing miR-143 vol.36, pp.11, 2017, https://doi.org/10.1089/dna.2017.3862
  14. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools vol.8, pp.10, 2017, https://doi.org/10.3390/genes8100217
  15. Temporal Trends in Geographical Variation in Breast Cancer Mortality in China, 1973–2005: An Analysis of Nationwide Surveys on Cause of Death vol.13, pp.10, 2016, https://doi.org/10.3390/ijerph13100963
  16. Art therapy for anxiety, depression, and fatigue in females with breast cancer: A systematic review pp.1540-7586, 2018, https://doi.org/10.1080/07347332.2018.1506855